Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13141-13149

  Kew, Chun ^a   Lui, Pak Yin ^a   Chan, Chi Ping ^a   Liu, Xiang ^b   Ngor Au, Shannon Wing ^c   Mohr, Ian ^d   Jin, Dong Yan ^a   Kok, Kin Hang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; PROTEIN PACT; PROTEIN US11; RETINOIC ACID INDUCIBLE PROTEIN I; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FIBROBLAST; HERPES SIMPLEX VIRUS 1; IMMUNE EVASION; INNATE IMMUNITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RNA ANALYSIS;

ANIMALS; DOWN-REGULATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RNA-BINDING PROTEINS; VIRAL PROTEINS;

EID: 84888057050     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02564-13     Document Type: Article

References (43)

1. Melchjorsen J. 2012. Sensing herpes:more than Toll. Rev. Med. Virol. 22:106-121.
2. Paladino P, Mossman KL. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29:599-607.
3. Boutell C, Everett RD. 2013. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. Gen. Virol. 94:465-481.
4. Broberg EK, Hukkanen V. 2005. Immune response to herpes simplex virus and γ134.5 deleted HSV vectors. Curr. Gene Ther. 5:523-530.
5. Cassady KA, Gross M, Roizman B. 1998. The herpes simplex virus US11 protein effectively compensates for the γ134.5 gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72:8620-8626.
6. Mulvey M, Poppers J, Ladd A, Mohr I. 1999. A herpesvirus ribosomeassociated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function. J. Virol. 73:3375-3385.
7. Poppers J, Mulvey M, Khoo D, Mohr I. 2000. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 74:11215-11221.
8. Mulvey M, Camarena V, Mohr I. 2004. Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and γ134.5 gene products. J. Virol. 78:10193-10196.
9. Ishioka K, Ikuta K, Sato Y, Kaneko H, Sorimachi K, Fukushima E, Saijo M, Suzutani T. 2013. Herpes simplex virus type 1 virion-derived US11 inhibits type 1 interferon-induced protein kinase R phosphorylation. Microbiol. Immunol. 57:426-436.
10. Roller RJ, Roizman B. 1990. The herpes simplex virus Us11 open reading frame encodes a sequence-specific RNA-binding protein. J. Virol. 64:3463-3470.
11. Khoo D, Perez C, Mohr I. 2002. Characterization of RNA determinants recognized by the arginine-and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J. Virol. 76:11971-11981.
12. Bryant KF, Cox JC, Wang H, Hogle JM, Ellington AD, Coen DM. 2005. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res. 33:6090-6100.
13. Peters GA, Khoo D, Mohr I, Sen GC. 2002. Inhibition of PACTmediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76:11054-11064.
14. Sanchez R, Mohr I. 2007. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. J. Virol. 81:3455-3464.
15. Xing J, Wang S, Lin R, Mossman KL, Zheng C. 2012. Herpes simplex virus 1 tegument protein Us11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. J. Virol. 86:3528-3540.
16. Lussignol M, Queval C, Bernet-Camard MF, Cotte-Laffitte J, Beau I, Codogno P, Esclatine A. 2013. The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR. J. Virol. 87:859-871.
17. Patel RC, Sen GC. 1998. PACT, a protein activator of the interferoninduced protein kinase, PKR. EMBO J. 17:4379-4390.
18. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
19. Goubau D, Deddouche S, Reis E, Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855-869.
20. Rasmussen SB, Jensen SB, Nielsen C, Quartin E, Kato H, Chen ZJ, Silverman RH, Akira S, Paludan SR. 2009. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible genelike receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90:74-78.
21. Melchjorsen J, Rintahaka J, Soby S, Horan KA, Poltajainen A, Ostergaard L, Paludan SR, Matikainen S. 2010. Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III independent pathways. J. Virol. 84:11350-11358.
22. da Silva LF, Jones C. 2013. Small non-coding RNAs encoded within the herpes simplex virus type 1 latency associated transcript (LAT) cooperate with the retinoic acid inducible gene I (RIG-I) to induce beta-interferon promoter activity and promote cell survival. Virus Res. 175:101-109.
23. Kok KH, Lui PY, Ng MH, Siu KL, Au SW, Jin DY. 2011. The doublestranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309.
24. Rowe TM, Rizzi M, Hirose K, Peters GA, Sen GC. 2006. A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc. Natl. Acad. Sci. U.S.A. 103:5823-5828.
25. Peters GA, Seachrist DD, Keri RA, Sen GC. 2009. The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc. Natl. Acad. Sci. U.S.A. 106:10696-10701.
26. Liu X, Houzet L, Jeang KT. 2012. Tombusvirus P19 RNA silencing suppressor (RSS) activity in mammalian cells correlates with charged amino acids that contribute to direct RNA-binding. Cell Biosci. 2:41. doi:10.1186/2045-3701-2-41.
27. Mulvey M, Poppers J, Sternberg D, Mohr I. 2003. Regulation of eIF2α phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J. Virol. 77:10917-10928.
28. Benboudjema L, Mulvey M, Gao Y, Pimplikar SW, Mohr I. 2003. Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PAT1 results in the redistribution of both polypeptides. J. Virol. 77:9192-9203.
29. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
30. Kok KH, Ng MH, Ching YP, Jin DY. 2007. Human TRBP and PACT interact with each other and associate with Dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 282:17649-17657.
31. Tang HM, Gao WW, Chan CP, Siu YT, Wong CM, Kok KH, Ching YP, Takemori H, Jin DY. 2013. LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology 10:40. doi:10.1186/1742-4690-10-40.
32. Siu KL, Kok KH, Ng MH, Poon VK, Yuen KY, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3 · TANK · TBK1/IKKe complex. J. Biol. Chem. 284:16202-16209.
33. Ng MH, Ho TH, Kok KH, Siu KL, Li J, Jin DY. 2011. MIP-T3 is a negative regulator of innate type I interferon response. J. Immunol. 187:6473-6482.
34. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791.
35. Paludan SR, Bowie AG. 2013. Immune sensing of DNA. Immunity 38:870-880.
36. Xiao TS, Fitzgerald KA. 2013. The cGAS-STING pathway for DNA sensing. Mol. Cell 51:135-139.
37. D'Acquisto F, Ghosh S. 2001. PACT and PKR:turning on NF-κB in the absence of virus. Sci. STKE 2001:re1. doi:10.1126/stke.2001.89.re1.
38. Li S, Min JY, Krug RM, Sen GC. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13-21.
39. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. 2000. Influenza A virus NS1 protein prevents activation of NF-κB and induction of α/β interferon. J. Virol. 74:11566-11573.
40. Cardenas WB, Loo YM, Gale M, Jr, Hartman AL, Kimberlin CR, Martinez-Sobrido L, Saphire EO, Basler CF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits α/β interferon production induced by RIG-I signaling. J. Virol. 80:5168-5178.
41. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ. 2011. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J. Virol. 85:2512-2523.
42. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. 2013. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14:74-84.
43. Kok KH, Jin DY. 2013. Balance of power in host-virus arms races. Cell Host Microbe 14:5-6.